TOP TIERMARKET NEWSWIRE
Movers explained · 2026-11-18

Archived explainer. For the current picture see today's TNDM page.

Why Is TANDEM DIABETES CARE (TNDM) Stock Up Today?

By the Top Tier Newswire AI Desk · November 18, 2026 at 9:43 AM ET · reviewed against 7 wire stories

TANDEM DIABETES CARE (TNDM) is up +5.42% in the latest session. Our newswire has captured 7 stories on TNDM across 4 sources in the last 36 hours, with AI sentiment reading bullish (avg 62/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Tandem Diabetes Care (TNDM) shares rose 5.42% to $17.99, driven primarily by an upgrade from Stifel and recent regulatory approvals. The stock gap up at the open following Stifel’s move to a Buy rating with a $26.00 price target.

What Happened

Stifel upgraded Tandem Diabetes Care to Buy from Hold, raising its price target to $26.00. The firm cited the company’s product pipeline, share gains, and improving margins as key drivers for the positive outlook. This action followed recent regulatory milestones, including FDA clearance for the Tubeless Tandem Mobi system and Health Canada approval for a t:slim X2 insulin pump license amendment. Additionally, the company appointed Jeannette Bankes as President and CEO. Barclays also recently adjusted its price target for the stock.

What The Data Shows

The stock opened at $17.99, a 5.5% gap from the prior close of $17.06. Intraday activity saw a session high of $18.29 and a low of $17.50, both recorded at 9:30 AM ET, with the last trade at $18.15. Volume stood at 0.2M shares, which is 0.1x the three-month daily average. Fundamentals show a market cap of $1.3B, with the company remaining unprofitable at a trailing twelve-month EPS of -0.72. Revenue grew 6.8% over the same period, while the net margin stood at -4.6%. The stock has a beta of 1.60 and trades within a 52-week range of $12.26 to $29.65. Over the last eight sessions, the stock moved 0.9% from $16.91 to $17.06. Recent SEC filings indicate one insider sale by Christopher J. Twomey on October 27, 2026, totaling $33K. Congressional disclosures show three buys and one sell in the last 90 days, including a purchase by Rep. Gilbert Ray Cisneros, Jr. in September 2026.

What To Watch

Investors will monitor the company’s progress in executing its product pipeline and integrating new leadership. The upcoming earnings date is not specified in the current data, but coverage breadth remains active with seven stories from four sources in the last 36 hours.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

TNDM by the numbers

Last: $17.99Session: +5.42%7 sessions: -6.16%Coverage: 7 stories / 4 sourcesAI sentiment: 62/100 (bullish)Mkt cap: $1.3B52w: $12.26 to $29.65
TNDM · Nov 18 session (5-min) · -0.11% vs prior close · updated 8:53 PM ET
$16.75$17.52$18.28prev close $17.06$17.047:00 AM9:27 AM11:55 AM2:22 PM4:50 PM7:00 AM · $18.007:20 AM · $17.807:35 AM · $17.997:40 AM · $17.968:00 AM · $17.908:10 AM · $18.058:25 AM · $17.978:30 AM · $17.978:50 AM · $17.938:55 AM · $18.049:25 AM · $17.679:30 AM · $18.209:35 AM · $18.059:40 AM · $18.169:45 AM · $17.659:50 AM · $17.619:55 AM · $17.6310:00 AM · $17.6310:05 AM · $17.6110:10 AM · $17.5810:15 AM · $17.5510:20 AM · $17.5210:25 AM · $17.7610:30 AM · $17.7410:35 AM · $17.5010:40 AM · $17.5910:45 AM · $17.5110:50 AM · $17.5510:55 AM · $17.5411:00 AM · $17.4911:05 AM · $17.3311:10 AM · $17.3411:15 AM · $17.3111:20 AM · $17.3811:25 AM · $17.4711:30 AM · $17.4611:35 AM · $17.4811:40 AM · $17.3711:45 AM · $17.3411:50 AM · $17.3411:55 AM · $17.4512:00 PM · $17.5312:05 PM · $17.4512:10 PM · $17.4112:15 PM · $17.4112:20 PM · $17.5412:25 PM · $17.4812:30 PM · $17.5412:35 PM · $17.4312:40 PM · $17.4312:45 PM · $17.4312:50 PM · $17.4512:55 PM · $17.381:00 PM · $17.291:05 PM · $17.131:10 PM · $17.221:15 PM · $17.301:20 PM · $17.311:25 PM · $17.241:30 PM · $17.171:35 PM · $17.091:40 PM · $17.201:45 PM · $17.111:50 PM · $17.071:55 PM · $17.052:00 PM · $17.012:05 PM · $16.952:10 PM · $16.952:15 PM · $16.892:20 PM · $16.832:25 PM · $16.892:30 PM · $16.892:35 PM · $16.932:40 PM · $16.912:45 PM · $16.952:50 PM · $16.922:55 PM · $16.903:00 PM · $16.853:05 PM · $16.953:10 PM · $16.993:15 PM · $17.083:20 PM · $17.043:25 PM · $17.073:30 PM · $16.963:35 PM · $17.003:40 PM · $16.963:45 PM · $16.993:50 PM · $17.163:55 PM · $17.054:00 PM · $17.054:05 PM · $17.054:40 PM · $17.054:50 PM · $17.04
AI sentiment, last 36h · averaged over 7 stories · 62/100 bullish
AI sentiment 62/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 7 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishThe Fly · sentiment 64 · Tandem Diabetes upgraded to Buy from Hold at StifelThe Fly · 64Tandem Diabetes upgraded to Buy from Hold at StifelThe Fly · sentiment 64 · Stifel upgrades Tandem to Buy, notes share gains and improving marginsThe Fly · 64Stifel upgrades Tandem to Buy, notes share gains and improving marginsGuruFocus · sentiment 67 · Stifel Upgrades Tandem Diabetes (TNDM) to Buy, Raising Price Target to $26GuruFocus · 67Stifel Upgrades Tandem Diabetes (TNDM) to Buy, Raising Price Target to $26Investing.com Analyst Ratings · sentiment 64 · Stifel upgrades Tandem Diabetes stock rating on product pipelineInvesting.com Analyst Ratings · 64Stifel upgrades Tandem Diabetes stock rating on product pipelineInvesting.com Markets · sentiment 63 · Why is Tandem Diabetes Care stock rallying today?Investing.com Markets · 63Why is Tandem Diabetes Care stock rallying today?GuruFocus · sentiment 64 · TNDM Upgraded by Stifel -- Price Target Raised to $26.00GuruFocus · 64TNDM Upgraded by Stifel -- Price Target Raised to $26.00The Fly · sentiment 50 · Insulet downgraded, Tandem Diabetes upgraded: Wall Street’s top analyst callsThe Fly · 50Insulet downgraded, Tandem Diabetes upgraded: Wall Street’s top analyst calls
2d agoThe FlyNEUTRAL 50Analyst

Insulet downgraded, Tandem Diabetes upgraded: Wall Street’s top analyst calls

2d agoGuruFocusBULLISH 64Analyst

TNDM Upgraded by Stifel -- Price Target Raised to $26.00

2d agoInvesting.com MarketsBULLISH 63General

Why is Tandem Diabetes Care stock rallying today?

Why is Tandem Diabetes Care stock rallying today?

2d agoInvesting.com Analyst RatingsBULLISH 64Analyst

Stifel upgrades Tandem Diabetes stock rating on product pipeline

Stifel upgrades Tandem Diabetes stock rating on product pipeline

2d agoGuruFocusBULLISH 67Analyst

Stifel Upgrades Tandem Diabetes (TNDM) to Buy, Raising Price Target to $26

2d agoThe FlyBULLISH 64Analyst

Stifel upgrades Tandem to Buy, notes share gains and improving margins

2d agoThe FlyBULLISH 64Analyst

Tandem Diabetes upgraded to Buy from Hold at Stifel

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on TNDM: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier TNDM move explainers: 2026-11-18 · 2026-11-13